97 related articles for article (PubMed ID: 33112109)
21. Correlation of genomic alterations assessed by next-generation sequencing (NGS) of tumor tissue DNA and circulating tumor DNA (ctDNA) in metastatic renal cell carcinoma (mRCC): potential clinical implications.
Hahn AW; Gill DM; Maughan B; Agarwal A; Arjyal L; Gupta S; Streeter J; Bailey E; Pal SK; Agarwal N
Oncotarget; 2017 May; 8(20):33614-33620. PubMed ID: 28431395
[TBL] [Abstract][Full Text] [Related]
22. Frequent allelic changes at chromosome 7q34 but lack of mutation of the BRAF in papillary renal cell tumors.
Nagy A; Balint I; Kovacs G
Int J Cancer; 2003 Oct; 106(6):980-1. PubMed ID: 12918080
[TBL] [Abstract][Full Text] [Related]
23. Mutation of the p53 tumour suppressor gene occurs preferentially in the chromophobe type of renal cell tumour.
Contractor H; Zariwala M; Bugert P; Zeisler J; Kovacs G
J Pathol; 1997 Feb; 181(2):136-9. PubMed ID: 9120715
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.
Kauffman EC; Barocas DA; Chen YT; Yang XJ; Scherr DS; Tu JJ
J Urol; 2009 May; 181(5):2305-11. PubMed ID: 19303095
[TBL] [Abstract][Full Text] [Related]
25. Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approach.
Fiorentino M; Gruppioni E; Massari F; Giunchi F; Altimari A; Ciccarese C; Bimbatti D; Scarpa A; Iacovelli R; Porta C; Virinder S; Tortora G; Artibani W; Schiavina R; Ardizzoni A; Brunelli M; Knuutila S; Martignoni G
Oncotarget; 2017 Jan; 8(5):7328-7335. PubMed ID: 27741505
[TBL] [Abstract][Full Text] [Related]
26. Cystic kidney disease, chromophobe renal cell carcinoma and TCF2 (HNF1 beta) mutations.
Lebrun G; Vasiliu V; Bellanné-Chantelot C; Bensman A; Ulinski T; Chrétien Y; Grünfeld JP
Nat Clin Pract Nephrol; 2005 Dec; 1(2):115-9. PubMed ID: 16932376
[TBL] [Abstract][Full Text] [Related]
27. Metastatic Chromophobe Renal Cell Carcinoma: Presence or Absence of Sarcomatoid Differentiation Determines Clinical Course and Treatment Outcomes.
Ged Y; Chen YB; Knezevic A; Casuscelli J; Redzematovic A; DiNatale RG; Carlo MI; Lee CH; Feldman DR; Patil S; Hakimi AA; Russo P; Motzer RJ; Voss MH
Clin Genitourin Cancer; 2019 Jun; 17(3):e678-e688. PubMed ID: 31036466
[TBL] [Abstract][Full Text] [Related]
28. Multifocal and microscopic chromophobe renal cell carcinomatous lesions associated with 'capsulomas' without FCLN gene abnormality.
Sugimoto K; Takasawa A; Ichimiya S; Murata M; Kimura H; Aoyama T; Gille JJ; Kuroda N; Shimizu H; Hasegawa T; Sawada N; Furuya M; Nagashima Y
Pathol Int; 2013 Oct; 63(10):510-5. PubMed ID: 24134681
[TBL] [Abstract][Full Text] [Related]
29. Genomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic Alterations.
Malouf GG; Ali SM; Wang K; Balasubramanian S; Ross JS; Miller VA; Stephens PJ; Khayat D; Pal SK; Su X; Sircar K; Tamboli P; Jonasch E; Tannir NM; Wood CG; Karam JA
Eur Urol; 2016 Aug; 70(2):348-57. PubMed ID: 26895810
[TBL] [Abstract][Full Text] [Related]
30. Microsatellite allelotyping differentiates chromophobe renal cell carcinomas from renal oncocytomas and identifies new genetic changes.
Nagy A; Buzogany I; Kovacs G
Histopathology; 2004 Jun; 44(6):542-6. PubMed ID: 15186268
[TBL] [Abstract][Full Text] [Related]
31. Mutation analysis of glial cell line-derived neurotrophic factor (GDNF), a ligand for the RET/GDNF receptor alpha complex, in sporadic phaeochromocytomas.
Dahia PL; Toledo SP; Mulligan LM; Maher ER; Grossman AB; Eng C
Cancer Res; 1997 Jan; 57(2):310-3. PubMed ID: 9000574
[TBL] [Abstract][Full Text] [Related]
32. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease.
Kim EH; Yum MS; Ra YS; Park JB; Ahn JS; Kim GH; Goo HW; Ko TS; Yoo HW
J Neurosurg; 2016 May; 124(5):1221-7. PubMed ID: 26430847
[TBL] [Abstract][Full Text] [Related]
33. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
[TBL] [Abstract][Full Text] [Related]
34. Detection of circulating cancer cells with von hippel-lindau gene mutation in peripheral blood of patients with renal cell carcinoma.
Ashida S; Okuda H; Chikazawa M; Tanimura M; Sugita O; Yamamoto Y; Nakamura S; Moriyama M; Shuin T
Clin Cancer Res; 2000 Oct; 6(10):3817-22. PubMed ID: 11051223
[TBL] [Abstract][Full Text] [Related]
35. Renal carcinoma associated with a novel succinate dehydrogenase A mutation: a case report and review of literature of a rare subtype of renal carcinoma.
Ozluk Y; Taheri D; Matoso A; Sanli O; Berker NK; Yakirevich E; Balasubramanian S; Ross JS; Ali SM; Netto GJ
Hum Pathol; 2015 Dec; 46(12):1951-5. PubMed ID: 26476567
[TBL] [Abstract][Full Text] [Related]
36. Somatic mitochondrial DNA mutations in human chromophobe renal cell carcinomas.
Nagy A; Wilhelm M; Sükösd F; Ljungberg B; Kovacs G
Genes Chromosomes Cancer; 2002 Nov; 35(3):256-60. PubMed ID: 12353267
[TBL] [Abstract][Full Text] [Related]
37. Frequency and significance of rare RNF213 variants in patients with adult moyamoya disease.
Jang MA; Chung JW; Yeon JY; Kim JS; Hong SC; Bang OY; Ki CS
PLoS One; 2017; 12(6):e0179689. PubMed ID: 28617845
[TBL] [Abstract][Full Text] [Related]
38. CCND1 rearrangements and cyclin D1 overexpression in renal oncocytomas: frequency, clinicopathologic features, and utility in differentiation from chromophobe renal cell carcinoma.
Sukov WR; Ketterling RP; Lager DJ; Carlson AW; Sinnwell JP; Chow GK; Jenkins RB; Cheville JC
Hum Pathol; 2009 Sep; 40(9):1296-303. PubMed ID: 19386349
[TBL] [Abstract][Full Text] [Related]
39. DAB2IP Plays Important Clinical Significance and Correlates With Immune Infiltration in Renal Cell Carcinoma.
Cao H; Zhang J; Wang W
Technol Cancer Res Treat; 2020; 19():1533033820936682. PubMed ID: 32583730
[TBL] [Abstract][Full Text] [Related]
40. A case of chromophobe renal cell carcinoma associated with low chromosome number and microsatellite instability.
Shuin T; Kondo K; Sakai N; Kaneko S; Yao M; Nagashima Y; Kitamura H; Yoshida MA
Cancer Genet Cytogenet; 1996 Jan; 86(1):69-71. PubMed ID: 8616791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
